Bacterial resistance to trimethoprim in geriatric medical wards

M J Bendall1, S Ebrahim, R G Finch

  • 1Department of Health Care of the Elderly, University of Nottingham Medical School, UK.

Gerontology
|January 1, 1989
PubMed

Insights

Trimethoprim-resistant urinary tract infections (UTIs) are common in geriatric wards, particularly in males. Faecal carriage of resistant organisms is linked to UTIs, with antimicrobial exposure being a key factor.

Area of Science:

  • Geriatric Medicine
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Urinary tract infections (UTIs) are a significant health concern in elderly populations.
  • Trimethoprim (TMP) resistance in UTI pathogens complicates treatment options.
  • Faecal carriage of antimicrobial-resistant organisms is a reservoir for infection.

Purpose of the Study:

  • To investigate the prevalence of TMP-resistant UTIs in geriatric wards.
  • To identify risk factors associated with TMP-resistant UTIs and faecal carriage.
  • To determine the relationship between faecal carriage and TMP-resistant UTIs.

Main Methods:

  • Study conducted in two geriatric wards.
  • Assessed prevalence of TMP-resistant UTIs and faecal carriage.
  • Analyzed associations with patient demographics, admission types, and length of stay.
  • Evaluated the impact of antimicrobial exposure on faecal carriage.

Main Results:

  • TMP-resistant UTIs were prevalent (26% on admission, 50% ward-acquired).
  • Risk factors included male sex, recurrent admissions, transfers, and longer hospital stays.
  • A strong correlation was observed between faecal carriage and TMP-resistant UTIs.
  • Antimicrobial exposure was identified as the primary determinant of TMP-resistant faecal carriage.

Conclusions:

  • TMP-resistant UTIs pose a substantial challenge in geriatric care.
  • Faecal carriage serves as a significant reservoir for TMP-resistant UTIs in this setting.
  • Minimizing antimicrobial exposure is crucial to control the spread of TMP resistance.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...